Beiersdorf Ag (BDRFF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Beiersdorf Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.318 -- 00:00:03.922 Good morning and welcome to Biosdorf's first quarter conference call. 00:00:03.922 -- 00:00:08.528 Thank you for joining us today. I'm here with our CEO, Vincent Warnery, as well as our 00:00:08.528 -- 00:00:13.314 CFO, Astrid Herrmann. We would like to share with you Biosdorf's sales performance of 00:00:13.314 -- 00:00:18.580 the first three months of 2025. We will start with a presentation of our results, followed 00:00:18.580 -- 00:00:23.446 by a Q&A session. And with that, I'd like to hand over to Vincent. 00:00:23.446 -- 00:00:27.713 Thank you, Christopher, and good morning. Welcome to today's conference call. 00:00:27.713 -- 00:00:32.020 Astrid and I will now guide you through our sales figures for the first three months 00:00:32.020 -- 00:00:34.624 of 2025. Following 00:00:34.624 -- 00:00:37.668 a very strong performance in 2024, 00:00:37.668 -- 00:00:42.897 Basel delivered against expectations in the first quarter of the new financial 00:00:42.897 -- 00:00:48.605 year. Our first quarter's results are influenced by a strong prior year base 00:00:48.605 -- 00:00:51.820 and support our outlook for the full year. 00:00:51.820 -- 00:00:56.887 Our derma business deserves again a special mention as we continue to see a strong 00:00:56.887 -- 00:01:02.053 performance. Eucerin delivers not only in our established markets, but 00:01:02.053 -- 00:01:06.179 also expands successfully into new countries. 00:01:06.179 -- 00:01:11.526 At the same time, we are setting the foundation for our future success in China. 00:01:11.526 -- 00:01:17.534 With proactive measures, we are refocusing on EVA business to win in skincare 00:01:17.534 -- 00:01:21.098 with strategic innovations in these key markets. 00:01:21.098 -- 00:01:26.886 Delivering bre...